
California, US residents click here
The job details are as follows:
Who We Are
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs.
United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF).
The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
Who You Are
You are an expert when it comes to Health Policy and Reimbursement. You understand how the different government agencies contribute to the health policy ecosystem and how they develop rulemaking on key pieces of legislation. You agree that relationships are best developed in-person and getting into in the trenches in Washinton DC is the best way to achieve the goals set forth. You have no fear when it comes to supporting and achieving the objectives for UT’s approved/pipeline products and first-in-class organ manufacturing pipeline.
The Senior/Health Policy and Pipeline Strategy Manager will serve as our internal and external subject matter expert for Health Policy related matters. Health Policy employee will assist the Director in developing and implementing strategies for Health Policy programs. This role will also support all commercially available products and align pipeline products in development with United Therapeutics commercial business objectives.
Minimum Requirements
Manager
Senior Manager
Preferred Qualifications
Location
United Therapeutics has the flexibility to hire this role remotely with ideal candidates residing in the DC Metro area.
The salary range for the Health Policy and Pipeline Strategy Manager is $121,000 - $161,000 and reflects our good-faith estimate of the compensation for this role at the time of posting.
The salary range for theSenior Health Policy and Pipeline Strategy Manager is $145,500 - $190,000 and reflects our good-faith estimate of the compensation for this role at the time of posting.
An employee’s position within the salary range will be based on factors such as education, qualifications, experience, skills, geographic location, and business needs, as well as other factors permitted by law at the time of posting. This range may be modified in the future based on company and market factors.
Eligible employees may participate in the Company’s comprehensive benefits suite of programs, including medical / dental / vision / prescription coverage, employee wellness resources, savings plans (401k and ESPP), paid time off & paid parental leave benefits, disability benefits, and more. For additional information on Company benefits, please visit https://www.unither.com/careers/benefits-and-amenities
United Therapeutics Corporation is an Equal Opportunity Employer, including veterans and individuals with disabilities.

Founded to find a cure for a daughter’s rare disease, United Therapeutics is a biotechnology company transforming care for people with chronic and life-threatening conditions. Our purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. We are bold and unconventional. We have fun, we do good. We are also the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation.